Basic Information
| LncRNA/CircRNA Name | AC026904.1 |
| Synonyms | NA |
| Region | GRCh38_8:48590401-48594621 |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | lung cancer |
| ICD-0-3 | C34 |
| Methods | qPCR, Western blot, Luciferase reporter assay etc |
| Sample | lung cancer tissues with or without metastasis,and the adjacent tissues, cell lines(H1299, A549) |
| Expression Pattern | up-regulated |
| Function Description | LncRNA AC026904.1 is upregulated by noncanonical TGF-? signaling in lung cancer cells.LncRNA AC026904.1 is highly expressed in metastatic lung cancer and negatively correlated with the overall survival of lung cancer patients. |
| Pubmed ID | 32270919 |
| Year | 2020 |
| Title | Long noncoding RNAs AC026904.1 is essentialfor TGF-?-induced migration and epithelial-mesenchymal transition through functioning as an enhancer of Slug in lung cancer cells |
External Links
| Links for AC026904.1 | GenBank HGNC NONCODE |
| Links for lung cancer | OMIM COSMIC |